Kothari Biotech Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 4.56 Cr
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 5.20 Cr
- Revenue Growth -13.55%
- Profit Growth 148.24%
- Ebitda 68.26%
- Net Worth 2.70%
- Total Assets 1.25%
About Kothari Biotech
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01409TN1995PTC030798
- Company No.
030798
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 1995
- Date of AGM
28 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Kothari Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjun Kothari  | Director | 06-Aug-2019 | Current |
| Nagarathnam Rangarajarathinam | Director | 10-Aug-2004 | Current |
| Rajan Prakash | Director | 28-Jul-2011 | Current |
Financial Performance of Kothari Biotech.
Kothari Biotech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 13.55% decrease. The company also saw a substantial improvement in profitability, with a 148.24% increase in profit. The company's net worth moved up by a moderate rise of 2.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kothari Biotech?
In 2021, Kothari Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kothari Sugars And Chemicals LimitedArjun Kothari is a mutual person
- Kothari Safe Deposits Limited
Arjun Kothari is a mutual person
Kothari Petrochemicals Limited.Arjun Kothari is a mutual person
Hck Napc Mines And Ores Private LimitedNagarathnam Rangarajarathinam is a mutual person
- Hck Capital Services Private Limited
Nagarathnam Rangarajarathinam and Arjun Kothari are mutual person
Charges (Loans)
₹0
₹5.20 Cr
Charges Breakdown by Lending Institutions
- Icici Limited : 4.70 Cr
- Centre For Technology Development : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 1999 | Icici Limited | ₹1.20 Cr | Satisfied |
| 02 Dec 1998 | Centre For Technology Development | ₹5.00 M | Satisfied |
| 24 Dec 1996 | Icici Limited | ₹1.00 Cr | Satisfied |
| 13 Sep 1996 | Icici Limited | ₹2.50 Cr | Satisfied |
How Many Employees Work at Kothari Biotech?
Kothari Biotech has a workforce of 1 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kothari Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kothari Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
